As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2. Imanis Life Sciences and Siemens Healthineers have both announced the development of their scalable quantitative neutralizing antibody assays, a noteworthy advancement from the +/- results yielded by widely used antibody tests.
With a quantitative test result, physicians and researchers can track neutralizing antibody titers over time to better understand the short- and long-term efficacy of COVID-19 vaccines.
Published November 19, 2020: https://www.bioworld.com/articles/500422-dueling-quantitative-covid-19-neutralizing-antibody-tests-roll-out-as-vaccines-approach-completion
For inquiries, please contact email@example.com